WallStreetZenWallStreetZen

NASDAQ: AUTL
Autolus Therapeutics PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for AUTL

Based on 2 analysts offering 12 month price targets for Autolus Therapeutics PLC.
Min Forecast
$9.00+85.95%
Avg Forecast
$9.50+96.28%
Max Forecast
$10.00+106.61%

Should I buy or sell AUTL stock?

Based on 2 analysts offering ratings for Autolus Therapeutics PLC.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AUTL stock forecasts and price targets.

AUTL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-12
lockedlocked$00.00+00.00%2023-12-13
lockedlocked$00.00+00.00%2023-11-09

1 of 1

Forecast return on equity

Is AUTL forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.72%

Forecast return on assets

Is AUTL forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

AUTL revenue forecast

What is AUTL's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$27.7M+1,529.21%
Avg 2 year Forecast
$69.4M+3,989.58%
Avg 3 year Forecast
$186.9M+10,904.77%
AUTL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AUTL revenue growth forecast

How is AUTL forecast to perform vs Biotechnology companies and vs the US market?
Company
368.18%
Industry
38.32%
Market
10.27%
AUTL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AUTL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AUTL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AUTL$4.84$9.50+96.28%Strong Buy
DAWN$14.85$38.25+157.58%Strong Buy
FDMT$25.30$50.71+100.45%Strong Buy
VRNA$16.40$33.67+105.29%Strong Buy
SYRE$34.31$38.00+10.75%Strong Buy
View Top Biotech Stocks

Autolus Therapeutics Stock Forecast FAQ

Is Autolus Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: AUTL) stock is to Strong Buy AUTL stock.

Out of 2 analysts, 1 (50%) are recommending AUTL as a Strong Buy, 1 (50%) are recommending AUTL as a Buy, 0 (0%) are recommending AUTL as a Hold, 0 (0%) are recommending AUTL as a Sell, and 0 (0%) are recommending AUTL as a Strong Sell.

If you're new to stock investing, here's how to buy Autolus Therapeutics stock.

What is AUTL's revenue growth forecast for 2024-2026?

(NASDAQ: AUTL) Autolus Therapeutics's forecast annual revenue growth rate of 368.18% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.32%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.27%.

Autolus Therapeutics's revenue in 2024 is $1,698,000.On average, 4 Wall Street analysts forecast AUTL's revenue for 2024 to be $7,356,585,302, with the lowest AUTL revenue forecast at $37,229,683, and the highest AUTL revenue forecast at $15,218,430,583. On average, 4 Wall Street analysts forecast AUTL's revenue for 2025 to be $18,466,188,546, with the lowest AUTL revenue forecast at $10,432,288,945, and the highest AUTL revenue forecast at $29,118,930,398.

In 2026, AUTL is forecast to generate $49,691,255,279 in revenue, with the lowest revenue forecast at $36,596,778,094 and the highest revenue forecast at $72,044,754,551.

What is AUTL's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: AUTL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is AUTL's Price Target?

According to 2 Wall Street analysts that have issued a 1 year AUTL price target, the average AUTL price target is $9.50, with the highest AUTL stock price forecast at $10.00 and the lowest AUTL stock price forecast at $9.00.

On average, Wall Street analysts predict that Autolus Therapeutics's share price could reach $9.50 by Apr 12, 2025. The average Autolus Therapeutics stock price prediction forecasts a potential upside of 96.28% from the current AUTL share price of $4.84.

What is AUTL's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: AUTL) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.